QQQ   280.53 (-0.41%)
AAPL   140.94 (-1.38%)
MSFT   244.37 (-0.31%)
META   113.93 (-0.17%)
GOOGL   94.94 (-2.10%)
AMZN   88.46 (+0.24%)
TSLA   174.04 (-3.21%)
NVDA   161.20 (+0.83%)
NIO   12.58 (-4.98%)
BABA   88.33 (-3.41%)
AMD   70.14 (-0.19%)
T   19.30 (+0.68%)
MU   53.82 (+0.26%)
CGC   3.24 (-10.25%)
F   13.10 (-1.36%)
GE   85.00 (-0.33%)
DIS   92.15 (-0.15%)
AMC   6.05 (-10.37%)
PYPL   74.42 (+3.03%)
PFE   50.24 (+1.07%)
NFLX   308.42 (+0.94%)
QQQ   280.53 (-0.41%)
AAPL   140.94 (-1.38%)
MSFT   244.37 (-0.31%)
META   113.93 (-0.17%)
GOOGL   94.94 (-2.10%)
AMZN   88.46 (+0.24%)
TSLA   174.04 (-3.21%)
NVDA   161.20 (+0.83%)
NIO   12.58 (-4.98%)
BABA   88.33 (-3.41%)
AMD   70.14 (-0.19%)
T   19.30 (+0.68%)
MU   53.82 (+0.26%)
CGC   3.24 (-10.25%)
F   13.10 (-1.36%)
GE   85.00 (-0.33%)
DIS   92.15 (-0.15%)
AMC   6.05 (-10.37%)
PYPL   74.42 (+3.03%)
PFE   50.24 (+1.07%)
NFLX   308.42 (+0.94%)
QQQ   280.53 (-0.41%)
AAPL   140.94 (-1.38%)
MSFT   244.37 (-0.31%)
META   113.93 (-0.17%)
GOOGL   94.94 (-2.10%)
AMZN   88.46 (+0.24%)
TSLA   174.04 (-3.21%)
NVDA   161.20 (+0.83%)
NIO   12.58 (-4.98%)
BABA   88.33 (-3.41%)
AMD   70.14 (-0.19%)
T   19.30 (+0.68%)
MU   53.82 (+0.26%)
CGC   3.24 (-10.25%)
F   13.10 (-1.36%)
GE   85.00 (-0.33%)
DIS   92.15 (-0.15%)
AMC   6.05 (-10.37%)
PYPL   74.42 (+3.03%)
PFE   50.24 (+1.07%)
NFLX   308.42 (+0.94%)
QQQ   280.53 (-0.41%)
AAPL   140.94 (-1.38%)
MSFT   244.37 (-0.31%)
META   113.93 (-0.17%)
GOOGL   94.94 (-2.10%)
AMZN   88.46 (+0.24%)
TSLA   174.04 (-3.21%)
NVDA   161.20 (+0.83%)
NIO   12.58 (-4.98%)
BABA   88.33 (-3.41%)
AMD   70.14 (-0.19%)
T   19.30 (+0.68%)
MU   53.82 (+0.26%)
CGC   3.24 (-10.25%)
F   13.10 (-1.36%)
GE   85.00 (-0.33%)
DIS   92.15 (-0.15%)
AMC   6.05 (-10.37%)
PYPL   74.42 (+3.03%)
PFE   50.24 (+1.07%)
NFLX   308.42 (+0.94%)
NASDAQ:APYX

Apyx Medical - APYX Stock Forecast, Price & News

$1.83
+0.01 (+0.55%)
(As of 12/7/2022 12:00 AM ET)
Add
Compare
Today's Range
$1.75
$1.85
50-Day Range
$1.40
$5.02
52-Week Range
$1.31
$14.50
Volume
106,022 shs
Average Volume
351,627 shs
Market Capitalization
$63.31 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.67

Apyx Medical MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.75 Rating Score
Upside/​Downside
318.9% Upside
$7.67 Price Target
Short Interest
Bearish
4.01% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.05
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.64) to ($0.55) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.11 out of 5 stars

Medical Sector

491st out of 1,027 stocks

Surgical & Medical Instruments Industry

54th out of 101 stocks

APYX stock logo

About Apyx Medical (NASDAQ:APYX) Stock

Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium to cut, coagulate and ablate soft tissue during open and laparoscopic surgical procedures. The company offers Renuvion branded products for the cosmetic surgery market that enable plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue to achieve their desired results; and J-Plasma branded products for the hospital surgical market. It also develops, manufactures, and sells disposable hand pieces, and OEM generators and accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

Receive APYX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Apyx Medical and its competitors with MarketBeat's FREE daily newsletter.

APYX Stock News Headlines

The WORST National Security Threat To The USA Since The 1973 Arab Oil Embargo?
Communist China has the USA in a resource stranglehold. They have a monopoly on this CRITICAL metal that we desperately need for military technology. In fact, both Trump AND Biden passed executive orders that addressed this crisis. And it could have a massive effect on smart investor's bank accounts.
The WORST National Security Threat To The USA Since The 1973 Arab Oil Embargo?
Communist China has the USA in a resource stranglehold. They have a monopoly on this CRITICAL metal that we desperately need for military technology. In fact, both Trump AND Biden passed executive orders that addressed this crisis. And it could have a massive effect on smart investor's bank accounts.
What Does Apyx Medical's Debt Look Like?
4APYX : Apyx Medical: Q2 Earnings Insights
See More Headlines
Receive APYX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Apyx Medical and its competitors with MarketBeat's FREE daily newsletter.

APYX Company Calendar

Last Earnings
11/10/2022
Today
12/07/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
3/16/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:APYX
Employees
272
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$7.67
High Stock Price Forecast
$10.00
Low Stock Price Forecast
$3.00
Forecasted Upside/Downside
+318.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
4 Analysts

Profitability

Net Income
$-15,170,000.00
Pretax Margin
-38.74%

Debt

Sales & Book Value

Annual Sales
$48.52 million
Book Value
$1.57 per share

Miscellaneous

Free Float
30,585,000
Market Cap
$63.31 million
Optionable
Optionable
Beta
1.36

Key Executives

  • Mr. Charles D. Goodwin II (Age 56)
    Pres, CEO & Director
    Comp: $892.97k
  • Ms. Tara H. Semb (Age 52)
    CFO, Treasurer & Sec.
    Comp: $531.67k
  • Mr. Moshe Citronowicz (Age 69)
    Sr. VP
    Comp: $432.49k
  • Mr. Todd Hornsby (Age 46)
    Exec. VP
    Comp: $590.66k













APYX Stock - Frequently Asked Questions

Should I buy or sell Apyx Medical stock right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Apyx Medical in the last twelve months. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" APYX shares.
View APYX analyst ratings
or view top-rated stocks.

What is Apyx Medical's stock price forecast for 2023?

4 equities research analysts have issued twelve-month price targets for Apyx Medical's shares. Their APYX share price forecasts range from $3.00 to $10.00. On average, they predict the company's share price to reach $7.67 in the next year. This suggests a possible upside of 318.9% from the stock's current price.
View analysts price targets for APYX
or view top-rated stocks among Wall Street analysts.

How have APYX shares performed in 2022?

Apyx Medical's stock was trading at $12.82 at the beginning of 2022. Since then, APYX stock has decreased by 85.7% and is now trading at $1.83.
View the best growth stocks for 2022 here
.

When is Apyx Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, March 16th 2023.
View our APYX earnings forecast
.

How were Apyx Medical's earnings last quarter?

Apyx Medical Co. (NASDAQ:APYX) released its earnings results on Thursday, November, 10th. The company reported ($0.17) earnings per share for the quarter, missing analysts' consensus estimates of ($0.12) by $0.05. The firm earned $9.11 million during the quarter, compared to analysts' expectations of $12 million. Apyx Medical had a negative net margin of 39.28% and a negative trailing twelve-month return on equity of 39.82%.

What guidance has Apyx Medical issued on next quarter's earnings?

Apyx Medical issued an update on its FY 2022 earnings guidance on Thursday, November, 10th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $44.80 million-$47.90 million, compared to the consensus revenue estimate of $53.47 million.

What other stocks do shareholders of Apyx Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Apyx Medical investors own include Main Street Capital (MAIN), Johnson & Johnson (JNJ), ONEOK (OKE), Occidental Petroleum (OXY), Procter & Gamble (PG), STORE Capital (STOR), Wells Fargo & Company (WFC), Boeing (BA), Bank of America (BAC) and Delta Air Lines (DAL).

What is Apyx Medical's stock symbol?

Apyx Medical trades on the NASDAQ under the ticker symbol "APYX."

Who are Apyx Medical's major shareholders?

Apyx Medical's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Pura Vida Investments LLC (4.36%), Vanguard Group Inc. (4.09%), Kent Lake Capital LLC (3.03%), Invenire Partners LP (2.74%), UBS Group AG (2.57%) and Royce & Associates LP (2.56%).
View institutional ownership trends
.

How do I buy shares of Apyx Medical?

Shares of APYX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Apyx Medical's stock price today?

One share of APYX stock can currently be purchased for approximately $1.83.

How much money does Apyx Medical make?

Apyx Medical (NASDAQ:APYX) has a market capitalization of $63.31 million and generates $48.52 million in revenue each year. The company earns $-15,170,000.00 in net income (profit) each year or ($0.56) on an earnings per share basis.

How many employees does Apyx Medical have?

The company employs 272 workers across the globe.

How can I contact Apyx Medical?

Apyx Medical's mailing address is 5115 Ulmerton Road, Clearwater FL, 33760. The official website for the company is www.apyxmedical.com. The company can be reached via phone at (727) 384-2323, via email at investor.relations@apyxmedical.com, or via fax at 800-323-1640.

This page (NASDAQ:APYX) was last updated on 12/7/2022 by MarketBeat.com Staff